Oncotarget cover image

Oncotarget

The Role of Kras and Canonical Wnt Pathways in Biliary Tract Cancers

Mar 2, 2023
Researchers discuss the role of Kras and canonical Wnt pathways in biliary tract cancers, highlighting the importance of understanding molecular mechanisms for developing effective therapies. Despite low survival rates, new research explores potential therapeutic targets and the impact of these pathways on biliary-tracked cancers.
06:41

Podcast summary created with Snipd AI

Quick takeaways

  • Mutations in KRAS and Wnt pathway activation drive biliary tract cancers' uncontrolled cell growth.
  • Combining therapies targeting KRAS and Wnt pathway shows promise for more effective biliary cancer treatments.

Deep dives

Role of KRAS and Canonical W&T Pathways in Biliary-Tracked Cancers

KRAS and the canonical W&T pathway play a vital role in the development of biliary-tracked cancers, such as gallbladder cancer and calendria carcinoma. Mutations in KRAS and abnormal activation of the W&T pathway contribute to uncontrolled cell growth and division in these cancers. Studies have shown that KRAS mutations are common in biliary cancers, activating downstream targets that promote tumor growth. Researchers from Kyoto University Graduate School of Medicine have explored the interaction between KRAS and the W&T pathway using a genetically engineered mouse model, highlighting the potential for targeted therapies.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner